Brady W. Dougan - Nov 16, 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Nov 16, 2025
Transactions value $
$0
Form type
4
Date filed
11/17/2025, 05:49 PM
Previous filing
Aug 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dougan Brady W Director 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM /s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact 2025-11-17 0001878020

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Award $0 +311K $0.00 311K Nov 16, 2025 Common Stock 311K $1.23 By spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 1/3 of the option becomes exercisable on February 14, 2026, after which 1/3 of the option will become exercisable on November 16, 2026, and the remaining 1/3 of the option will become exercisable on November 16, 2027.